{
    "organizations": [],
    "uuid": "a8deea2026799ed52090e7e93488b2ca8214be30",
    "author": "Peter Loftus",
    "url": "https://www.wsj.com/articles/reducing-use-of-roche-drug-for-breast-cancer-didnt-hurt-efficacy-study-says-1526504401",
    "ord_in_thread": 0,
    "title": "Reducing Use of Roche Drug for Breast Cancer Didn’t Hurt Efficacy, Study Says",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Treating breast-cancer patients with an expensive Roche Holding AG drug for six months instead of 12 reduced the medication’s heart-related side effects and its costs without sacrificing its effectiveness in preventing relapses, a new study found.\nThe study, funded by the U.K. National Institute for Health Research, was conducted on more than 4,000 women in the early stages of an aggressive type of breast cancer known as HER2-positive.\n... ",
    "published": "2018-05-17T01:00:00.000+03:00",
    "crawled": "2018-05-17T01:10:19.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "treating",
        "patient",
        "expensive",
        "roche",
        "holding",
        "ag",
        "drug",
        "six",
        "month",
        "instead",
        "reduced",
        "medication",
        "side",
        "effect",
        "cost",
        "without",
        "sacrificing",
        "effectiveness",
        "preventing",
        "relapse",
        "new",
        "study",
        "found",
        "study",
        "funded",
        "national",
        "institute",
        "health",
        "research",
        "conducted",
        "woman",
        "early",
        "stage",
        "aggressive",
        "type",
        "breast",
        "cancer",
        "known"
    ]
}